| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/BIMJ.201200053 |
| P698 | PubMed publication ID | 23553644 |
| P5875 | ResearchGate publication ID | 236104568 |
| P894 | zbMATH Open document ID | 1441.62283 |
| P2093 | author name string | Ionut Bebu | |
| George Luta | |||
| Vladimir Dragalin | |||
| P2860 | cites work | Testing and estimation in flexible group sequential designs with adaptive treatment selection | Q36327917 |
| Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts | Q36593604 | ||
| Drop-the-Losers Design: Binomial Case | Q37124957 | ||
| Adaptive designs for confirmatory clinical trials | Q37389417 | ||
| Viewpoints on the FDA Draft Adaptive Designs Guidance from the PhRMA Working Group | Q44253278 | ||
| Sequential designs for phase III clinical trials incorporating treatment selection | Q44315582 | ||
| Unbiased estimation of selected treatment means in two-stage trials | Q44443386 | ||
| Impacts on type I error rate with inappropriate use of learn and confirm in confirmatory adaptive design trials | Q45778475 | ||
| Dose selection in seamless phase II/III clinical trials based on efficacy and safety. | Q46029341 | ||
| Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology | Q46054107 | ||
| Two-stage design for dose-finding that accounts for both efficacy and safety. | Q51871777 | ||
| Bayesian predictive power for interim adaptation in seamless phase II/III trials where the endpoint is survival up to some specified timepoint. | Q51911840 | ||
| Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: opportunities and limitations. | Q51933435 | ||
| Drop-the-losers design: normal case. | Q51968007 | ||
| Evaluation of experiments with adaptive interim analyses. | Q52364596 | ||
| Monitoring pairwise comparisons in multi-armed clinical trials. | Q52376256 | ||
| Multiplicity and flexibility in clinical trials. | Q53025596 | ||
| Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations. | Q54188469 | ||
| Adaptive Dunnett tests for treatment selection | Q57305793 | ||
| Recursive Combination Tests | Q57305829 | ||
| Estimation in flexible two stage designs | Q57305870 | ||
| A group-sequential design for clinical trials with treatment selection | Q57430672 | ||
| Estimation following selection of the largest of two normal means | Q57430684 | ||
| An Adaptive Group Sequential Design for Phase II/III Clinical Trials that Select a Single Treatment From Several | Q57430779 | ||
| Point estimates and confidence regions for sequential trials involving selection | Q57430795 | ||
| Likelihood inference for a two-stage design with treatment selection | Q57721619 | ||
| P433 | issue | 3 | |
| P921 | main subject | confidence interval | Q208498 |
| P6104 | maintained by WikiProject | WikiProject Mathematics | Q8487137 |
| P304 | page(s) | 294-309 | |
| P577 | publication date | 2013-04-03 | |
| P1433 | published in | Biometrical Journal | Q15720842 |
| P1476 | title | Confidence intervals for confirmatory adaptive two-stage designs with treatment selection | |
| P478 | volume | 55 |
Search more.